Comparative effectiveness of psychotherapy approaches on Death Anxiety in Multiple Sclerosis Patients. A pilot randomized controlled trial

被引:7
作者
Lotfifar, Behnam [1 ]
Ghadampour, Ezatolah [2 ]
Bagheri, Nasrin [3 ]
机构
[1] Islamic Azad Univ, Boroujerd Branch, Dept Psychol, Boroujerd, Iran
[2] Lorestan Univ, Fac Literature & Human, Dept Psychol, Khorramabad, Iran
[3] Roudehen Azad Univ, Fac Psychol & Educ Sci, Dept Psychol, Tehran, Iran
关键词
Multiple sclerosis; Logotherapy; Acceptance and commitment therapy; Death Anxiety; LOGOTHERAPY; WOMEN;
D O I
10.1016/j.msard.2021.102914
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Death anxiety (DA) in chronic diseases has occupied the human mind more than other diseases. Therefore, multiple sclerosis (MS) patients are more prone to DA due to recurrence periods. Objective: Among the psychological interventions the two approaches of logotherapy (LT) and acceptance and commitment therapy (ACT), They pay more attention and concentration on the subject of suffering. Therefore, the present study aimed to compare the effectiveness of these two approaches on DA in MS patients. Methods: The statistical population included 48 women who were diagnosed as MS patients and had medical records at Iran MS Society in Tehran, in terms of entry and exit criteria, which were selected by convenience sampling. Then they were randomly divided into two experimental groups and one control group. This plan has an independent variable at three levels including: LT, ACT and the control group. The dependent variables are the subjects' scores on the Death Attitude Profile-Revised (DAP-R) (Wong., Reker & Gesser, 1994). Therapeutic interventions included 12 sessions of 2 h per week. A 3-hour workshop was held for the control group. in which patients were provided with basic information about the psychological problems of MS, but no strategy was presented. In order to obtain the results, the analysis of covariance was used and in the follow-up study, repeated measures analysis of variance with an intergroup variable (mixed model) was used. Results: It showed that both LT and ACT groups were able to be effective and reduce DA in comparison with the control group and such a positive effect on the improvement of DA was evident both in the post-test and follow-up stages. However, no significant differences were observed in comparing the effectiveness of the two intervention methods, so both methods were effective in reducing DA due to the nature of suffering. Conclusion: Considering the effectiveness of LT and ACT in reducing DA in MS patients, the results of this study can be used in order to achieve therapeutic goals and reduce psychological problems in chronic diseases.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Effectiveness of mindfulness-integrated cognitive behavior therapy on anxiety, depression and hope in multiple sclerosis patients: a randomized clinical trial
    Pouyanfard, Sahar
    ParviziFard, Ali A.
    Mohammadpour, Mohsen
    Sadeghi, Kheirollah
    TRENDS IN PSYCHIATRY AND PSYCHOTHERAPY, 2020, 42 (01) : 55 - 63
  • [22] Massage therapy and exercise therapy in patients with multiple sclerosis: a randomized controlled pilot study
    Negahban, Hossein
    Rezaie, Solmaz
    Goharpey, Shahin
    CLINICAL REHABILITATION, 2013, 27 (12) : 1126 - 1136
  • [23] The feasibility of Pilates to improve symptoms of anxiety, depression, and fatigue among people with Multiple Sclerosis: An eight-week randomized controlled pilot trial
    Fleming, Karl M.
    Coote, Susan B.
    Herring, Matthew P.
    PSYCHOLOGY OF SPORT AND EXERCISE, 2019, 45
  • [24] The Effectiveness of Mindfulness-Integrated Cognitive Behavior Therapy on Depression, Anxiety, and Stress in Females with Multiple Sclerosis: A Single Blind Randomized Controlled Trial
    Bahrani, Shima
    Zargar, Fatemeh
    Yousefipour, Gholamali
    Akbari, Hossein
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2017, 19 (04)
  • [25] Tibial nerve stimulation in the management of primary sexual dysfunction in patients with multiple sclerosis: a pilot randomized control trial
    Giannopapas, Vasileios
    Smyrni, Vassiliki
    Kitsos, Dimitrios K.
    Chasiotis, Athanasios K.
    Stavrogianni, Konstantina
    Papagiannopoulou, Georgia
    Tsivgoulis, Georgios
    Voumvourakis, Konstantinos
    Giannopoulos, Sotirios
    Bakalidou, Daphne
    NEUROLOGICAL SCIENCES, 2024, 45 (12) : 5849 - 5858
  • [26] The effect of traditional dysphagia therapy on the swallowing function in patients with Multiple Sclerosis: A pilot double-blinded randomized controlled trial
    Tarameshlu, Maryam
    Ghelichi, Leila
    Azimi, Amir Reza
    Ansari, Noureddin Nakhostin
    Khatoonabadi, Ahmad Reza
    JOURNAL OF BODYWORK AND MOVEMENT THERAPIES, 2019, 23 (01) : 171 - 176
  • [27] Aspirin is an effective pretreatment for exercise in multiple sclerosis: A double-blind randomized controlled pilot trial
    Leavitt, Victoria M.
    Blanchard, Adam R.
    Guo, Chu-Yueh
    Gelernt, Eva
    Sumowski, James F.
    Stein, Joel
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (11) : 1511 - 1513
  • [28] Arm Ergometry to Improve Mobility in Progressive Multiple Sclerosis (AMBOS)-Results of a Pilot Randomized Controlled Trial
    Heinrich, Inga
    Rosenthal, Friederike
    Patra, Stefan
    Schulz, Karl-Heinz
    Welsch, Goetz H.
    Vettorazzi, Eik
    Rosenkranz, Sina C.
    Stellmann, Jan Patrick
    Ramien, Caren
    Poettgen, Jana
    Gold, Stefan M.
    Heesen, Christoph
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [29] Impact of Mindfulness Training on Emotion Regulation in Multiple Sclerosis: Secondary Analysis of a Pilot Randomized Controlled Trial
    Duraney, Elizabeth Jean
    Fisher, Megan E.
    Manglani, Heena R.
    Andridge, Rebecca R.
    Nicholas, Jacqueline A.
    Prakash, Ruchika Shaurya
    REHABILITATION PSYCHOLOGY, 2022, 67 (04) : 449 - 460
  • [30] Effect of methylphenidate on oculomotor function in individuals with multiple sclerosis: a pilot randomized placebo-controlled trial
    Rich, Timothy J.
    Alexander, Aubree
    Dobryakova, Ekaterina
    Chiaravalloti, Nancy D.
    Deluca, John
    Costa, Silvana L.
    FRONTIERS IN NEUROLOGY, 2024, 15